This is a Validated Antibody Database (VAD) review about human TAB3, based on 5 published articles (read how Labome selects the articles), using TAB3 antibody in all methods. It is aimed to help Labome visitors find the most suited TAB3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TAB3 synonym: MAP3K7IP3; NAP1
Knockout validation
Cell Signaling Technology domestic rabbit monoclonal (D5J7D) |
| In order to study the activation of TAK1 by interleukin-1 and TRAF6, Cell Signaling Technology TAB3 antibody (Cell Signaling, 14241) was used in western blot knockout validation on human samples (fig 1a). Biochem J (2017) ncbi |
Abcam
domestic rabbit monoclonal (EPR5965) |
| Abcam TAB3 antibody (Abcam, ab124723) was used in western blot on human samples (fig 6). PLoS ONE (2016) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (D-9) |
| Santa Cruz Biotechnology TAB3 antibody (SantaCruz, sc-166538) was used in immunohistochemistry - paraffin section on human samples (fig 3a) and in western blot on human samples (fig 7a). Cell Prolif (2016) ncbi |
Cell Signaling Technology
domestic rabbit monoclonal (D5J7D) |
| Cell Signaling Technology TAB3 antibody (Cell Signaling, 14241) was used in western blot on human samples at 1:1000 (fig 7e). Proc Natl Acad Sci U S A (2021) ncbi |
domestic rabbit monoclonal (D5J7D) |
| In order to study the activation of TAK1 by interleukin-1 and TRAF6, Cell Signaling Technology TAB3 antibody (Cell Signaling, 14241) was used in western blot knockout validation on human samples (fig 1a). Biochem J (2017) ncbi |
domestic rabbit monoclonal (D5J7D) |
| Cell Signaling Technology TAB3 antibody (cell signalling, 14241) was used in western blot on human samples (fig 3b). Nucleic Acids Res (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments